Nasal administration is used for administering drugs that are insufflated via nose for systemic or local effect. Nasal delivery is used for treating local infection caused in the paranasal sinuses and the nasal course. Nasal drug delivery can also be used for minimizing the issues of poor bioavailability, slow absorption of drug, and degradation before it reaches its target location. This is a reliable and convenient route of administration.
The global nasal drug delivery mode market is forecast to be valued at US$ 50,947.4 Million over the forecast period.
COVID-19 is estimated to boost growth of the global nasal drug delivery mode market over the forecast period. COVID-19 was caused due to novel coronavirus and it is a respiratory disease. For instance, SaNOtize Research & Development Corporation and Glenmark Pharmaceuticals partnered up for manufacturing, marketing and distributing Nitric Oxide Nasal Sprays in India, along with Asian markets like Singapore, Hong Kong, Malaysia and many others in August 2021.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5047
Rising development of OTC drugs by major players is estimated to provide productive chances for the global nasal drug delivery mode market growth forecast period. For instance, Janssen Pharmaceuticals declared that they received approval from the U.S. FDA for SPRAVATO CIII nasal spray in March 2019, which is used in conjunction with an oral antidepressant for adults suffering with TRD (treatment-resistant depression).
Increasing regulatory challenges and complications related to the overusing of nasal sprays is estimated to restrain growth of the global nasal drug delivery mode market over the forecast period.
Impact of Covid-19:
Intranasal drug delivery is a vital area of research in COVID-19 and various viral diseases. Serum Institute of India and Codagenix gained regulatory approvals from the UK Medicines and Healthcare products Regulatory Agency for initiating the phase I clinical trials of their COVID-19 vaccine, COVI-VAC, which is a single-dose intranasal live attenuated vaccine. Eureka Therapeutics declared the successful preclinical results of their InvisiMask Human Antibody Nasal Spray in December 2020, against SARS-CoV-2 infection. This is estimated to propel growth of the global nasal drug delivery mode market.
The global nasal drug delivery mode market was forecast to be valued at US$ 48,200.0 Million in 2020 and is estimated to reach a value of US$ 75,766.8 Million by 2028 over the forecast period.
Asthma segment, among the therapeutic application segment in the in the global nasal drug delivery mode market is estimated to witness robust growth over the forecast period, and it is anticipated to account for 45.2% share in terms of value.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5047
- Rising number of novel products by key players is anticipated to augment growth of the global nasal drug delivery mode market over the forecast period. For instance, Oyster Point Pharma declared that they have gained approval form the FDA in October 2021, for their Tyrvaya, a nasal spray used for treating chronic dry eye condition
- Growing focus for developing novel products is estimated to fuel growth of the global nasal drug delivery mode market over the forecast period. For instance, Atai Life Sciences developed a start-up in order to nose-to-brain delivery system in August 2021, this can be used for treating mental health disorders. This start-up is called as InnarisBio.
Key players active in the global nasal drug delivery mode market are Dickinson and Company, Astra Zeneca, Becton, GlaxoSmithKline Plc, Aptar Group, Mystic Pharmaceuticals, Johnson & Johnson Services Inc., PendoPharm Inc., Neurelis Inc., Bausch Health, Optinose, 3M, ENT Technologies Pty Ltd., Cadila Pharmaceuticals and Dr. Reddy Laboratories.
- GlaxoSmithKline plc declared that they have gained approval from the FDA in July 2021, for Nucala (mepolizumab), which is a monoclonal antibody targeting interleukin-5 (IL-5). This can be used for treating patients suffering from chronic rhinosinusitis using nasal polyps.
- Lannett Company, Inc. declared that they have gained approval for their new drug Numbrino, by the FDA in January 2020.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Nasal Drug Delivery Mode Market Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Nasal Drug Delivery Mode Market Industry Impact
Chapter 2 Global Nasal Drug Delivery Mode Market Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nasal Drug Delivery Mode Market (Volume and Value) by Type
2.3 Global Nasal Drug Delivery Mode Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Nasal Drug Delivery Mode Market Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Nasal Drug Delivery Mode Market Market Analysis
Chapter 6 East Asia Nasal Drug Delivery Mode Market Market Analysis
Chapter 7 Europe Nasal Drug Delivery Mode Market Market Analysis
Chapter 8 South Asia Nasal Drug Delivery Mode Market Market Analysis
Chapter 9 Southeast Asia Nasal Drug Delivery Mode Market Market Analysis
Chapter 10 Middle East Nasal Drug Delivery Mode Market Market Analysis
Chapter 11 Africa Nasal Drug Delivery Mode Market Market Analysis
Chapter 12 Oceania Nasal Drug Delivery Mode Market Market Analysis
Chapter 13 South America Nasal Drug Delivery Mode Market Market Analysis
Chapter 14 Company Profiles and Key Figures in Nasal Drug Delivery Mode Market Business
Chapter 15 Global Nasal Drug Delivery Mode Market Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5047
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027